Facilities And InfrastructureThe company has inaugurated a new manufacturing facility in South Salt Lake to manufacture its patented Co-Primers oligonucleotides, the Co-Dx PCR Pro instrument, and test cups for the new Co-Dx PCR platform.
Manufacturing ExpansionProduction work flows are streamlined, efficiently staffed and ready for expansion in the company's new manufacturing facility in South Salt Lake.
Product DevelopmentThe company plans to submit the next iteration of the Co-Dx PCR COVID-19 test for 510(k) OTC clearance, following the collection of clinical evaluation data to support the new test's performance.